Skip to content
10-Q

Quarterly Report

Luckwel Pharmaceuticals Inc.

0001493152-19-012580

← back to feed
Filed
Aug 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Aug 14, 2019 143.38M sh
Cash And Equivalents Q1 2020 · Jun 30, 2019 $72.39K
Cash And Equivalents Q1 2020 · Mar 31, 2019 $25.75K
Total Liabilities Q1 2020 · Jun 30, 2019 $1.02M
Total Liabilities Q1 2020 · Mar 31, 2019 $819.09K
Total Assets Q1 2020 · Jun 30, 2019 $85.53K
Total Assets Q1 2020 · Mar 31, 2019 $27.27K
Operating Cash Flow Q1 2020 · Jun 30, 2018 −$212.89K
Stockholders Equity Q1 2020 · Jun 30, 2018 −$389.65K
Stockholders Equity Q1 2020 · Mar 31, 2018 −$129.3K
Sga Expense Q1 2020 · Jun 30, 2018 $220.36K
Net Income Q1 2020 · Jun 30, 2018 −$220.35K